SCHEMBL194830

SCHEMBL194830

CC(O)N(C(N)=O)C(C)O

nearest known ligand 0.46

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 14/20 0.46
TP53 P04637 1/20 0.35
LMNA P02545 1/20 0.33
ALOX15 P16050 1/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21748 0.78 ALOX5 (0.42) ALOX5LMNAALOX15BLMPMP22
SCHEMBL224542 0.77 ALOX5 (0.38) ALOX5TP53LMNAALOX15BLM
Hydrochloric Acid SCHEMBL13519387 0.75 ALOX5 (0.41) ALOX5LMNAALOX15BLMPMP22
SCHEMBL6531906 0.75 ALOX5 (0.41) ALOX5LMNAALOX15BLMPMP22
SCHEMBL27729016 0.75 ALOX5 (0.41) ALOX5LMNAALOX15BLMPMP22
SCHEMBL29277007 0.75 ALOX5 (0.41) ALOX5TP53LMNAALOX15BLM
SCHEMBL193411 0.73 TP53 (0.39) ALOX5TP53LMNA
SCHEMBL11055327 0.73 ALOX5 (0.33) ALOX5LMNA
SCHEMBL19641937 0.73 ALOX5 (0.39) ALOX5LMNAALOX15BLMPMP22
SCHEMBL7971508 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 303 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4171489-B1 SANITIZING COMPOSITION UNILEVER IP HOLDINGS B V (NL) 2026-03-25 EP claimed
WO-2025003367-A1 VITAMIN COMPOSITION FOR USE IN COSMETIC FORMULATIONS CLARIANT INTERNATIONAL LTD (CH) 2025-01-02 WO claimed
US-20230255868-A1 SANITIZING COMPOSITION CONOPCO, INC., D/B/A UNILEVER (US) 2023-08-17 US claimed
EP-4171489-A1 SANITIZING COMPOSITION Unilever IP Holdings B.V. (NL) 2023-05-03 EP claimed
WO-2022002882-A1 SANITIZING COMPOSITION UNILEVER IP HOLDINGS B.V. (NL) 2022-01-06 WO claimed
US-4246361-A Method for producing flame- and smoke-resistant polyurethane foam sheet by incorporation of a urea derivative in reaction mixture BRIDGESTONE TIRE CO., LTD. (JP) 1981-01-20 US claimed
US-4203892-A REACTING WITH A SUBSTITUTED UREA OR THIOUREA, DEGRADED AND DIGESTED IN THE INTESTINES VS. THE RUMEN THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1980-05-20 US claimed
US-20260090969-A1 COMPOSITIONS THAT PROTECT CELLS FROM OXIDATIVE AND MITOCHONDRIAL STRESS Nuchido Limited (GB) 2026-04-02 US disclosed
EP-4171489-B1 SANITIZING COMPOSITION UNILEVER IP HOLDINGS B V (NL) 2026-03-25 EP disclosed
EP-4547213-B1 ANTI-ACNE COMPOSITION UNILEVER IP HOLDINGS B V (NL) 2026-01-14 EP disclosed
US-20250243143-A1 1,3-Fatty Diol Compounds And Derivatives Thereof AGAIN BIO APS (DK) 2025-07-31 US disclosed
WO-2025149337-A1 TOPICAL SKIN IMPROVEMENT COMPOSITION UNILEVER IP HOLDINGS B.V. (NL) 2025-07-17 WO disclosed
WO-2025149314-A1 TOPICAL SKIN COMPOSITION UNILEVER IP HOLDINGS B.V. (NL) 2025-07-17 WO disclosed
US-4546121-A FLAMEPROOFING AGENTS BAYER AKTIENGESELLSCHAFT (DE) 1985-10-08 US disclosed
US-4231920-A METAL SALTS OF SULFONIC ACID AND A COSOLVENT GENERAL ELECTRIC COMPANY (US) 1980-11-04 US disclosed
US-4203892-A REACTING WITH A SUBSTITUTED UREA OR THIOUREA, DEGRADED AND DIGESTED IN THE INTESTINES VS. THE RUMEN THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1980-05-20 US disclosed
US-4202987-A CHAIN EXTENDERS AND CROSSLINKING AGENTS CIBA-GEIGY CORPORATION (US) 1980-05-13 US disclosed
US-4191835-A CHAIN EXTENSION, CROSSLINKING, POLYURETHANES CIBA-GEIGY CORPORATION (US) 1980-03-04 US disclosed
US-4178161-A IMPREGNATION OF NESTED SHEETS WITH A THERMOSETTING MELAMINE, UREA, OR BENZOGUANAMINE RESIN TENNECO CHEMICALS, INC. (US) 1979-12-11 US disclosed
US-4082704-A POLYURETHANE FOAM OF INCREASED RIGIDITY TENNECO CHEMICALS, INC. (US) 1978-04-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260090969-A1 COMPOSITIONS THAT PROTECT CELLS FROM OXIDATIVE AND MITOCHONDRIAL STRESS NLN, TFAM, CYP27B1 ALOX5 921/4885TP53 1670/4885LMNA 75/4885
US-20250243143-A1 1,3-Fatty Diol Compounds And Derivatives Thereof DGAT1, DGAT2, DSG1 ALOX5 62/4885TP53 859/4885LMNA 3971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.